Cord tissue banking involves the collection, processing and storage of the stem cells found within the cord. The collection of cord tissue does NOT harm the mother or the baby.
Cord tissue contains many cell types including Mesenchymal Stem Cells (MSCs), Epithelial Stem Cells, Endothelial Cells and Perivascular Cells. Cord tissue also possesses trophic factors which promote cellular growth, differentiation, and survival.
These cells and trophic factors hold considerable promise in regenerative medicine for the possible treatment of many medical conditions and diseases that are untreatable today.
Some of the therapeutic areas being researched using these types of cells are for Heart and Vascular Disease, Neurological Diseases, Autoimmune Diseases, Skeletal Disease and Injuries, Lung Disease, Skin Injuries and Gastrointestinal Disease.1
The following is an example of the potential of cord tissue derived stem cells. In a recent clinical trial reported in the Journal of the American Heart Association ®, the infusion of umbilical cord derived MSCs showed "significant" improvement in the hearts' ability to pump blood in the year following treatment and improved quality of life with no adverse effects.2
The CORD:USE method of shipping, processing, and cryopreservation of cord tissue has been shown to consistently produce over 1 billion mesenchymal stem cells after thawing and culturing the cord tissue cells.
1 - The existence of research or clinical trials does not guarantee that the cells or trophic factors found In cord tissue will be successful in the treatment of these diseases and conditions In the future.
2 - Jorge G Bartoluccl. et al. -Safety and Efficacy of Intravenous Infusion of Umbilical Cord adesenchymal Stem Cells in Patents with Heart failure: A Phase 1 / 2 Randomized Controlled Trial (RIIRECARD Trial). Circulation Research, Journal of the American Heart Association, 2017, September 26